MRSA Nasal Carriage – Al-Reyada University

Published on
Embed video
Share video
Ask about this video

Scene 1 (0s)

PREVALENCE OF NASAL CARRIAGE. METHICILLIN-RESISTANT.

Scene 2 (23s)

[image]. CHAPTER 01. INTRODUCTION and BACKGROUND.

Scene 3 (34s)

WHAT IS MRSA?. Methicillin-Resistant Staphylococcus aureus — a global antimicrobial resistance threat.

Scene 4 (1m 10s)

JUSTIFICATION. Why This Study. › METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS is resistant to commonly-used antibiotics, complicating treatment and increasing healthcare burden..

Scene 5 (1m 33s)

OBJECTIVES. General. Determine the prevalence of MRSA nasal carriage and associated risk factors among Al-Reyada University students..

Scene 6 (1m 50s)

[image]. CHAPTER 02. LITERATURE REVIEW. Historical background · Pathophysiology · Clinical features · Global prevalence.

Scene 7 (1m 59s)

HISTORICAL TIMELINE of MRSA. From first discovery to a global public health crisis.

Scene 8 (2m 23s)

PATHOPHYSIOLOGY and VIRULENCE of MRSA. Core Resistance Mechanism.

Scene 9 (2m 41s)

GLOBAL and REGIONAL MRSA PREVALENCE. 27.1%. Global (WHO 2025).

Scene 10 (3m 18s)

[image]. CHAPTER 03. MATERIALS and METHODS. Study design · Population · Sampling strategy · Lab protocols · Ethics.

Scene 11 (3m 27s)

STUDY DESIGN and POPULATION. Study Design. Study Type.

Scene 12 (3m 43s)

STUDY DESIGN and POPULATION. INCLUSION CRITERIA. ✓ Enrolled Al-Reyada undergrads ✓ Age ≥ 18 years; both genders ✓ Written informed consent ✓ No symptoms at sample collection.

Scene 13 (3m 59s)

STUDY DESIGN and POPULATION. Proportional Stratified Sample Distribution (n = 150).

Scene 14 (4m 14s)

STUDY DESIGN and POPULATION. Proportional Stratified Sample Distribution (n = 150).

Scene 15 (4m 29s)

LABORATORY METHODS. 1. Nasal Swab Collection. 2. Transport & Plating.

Scene 16 (4m 45s)

LABORATORY METHODS. 1. Nasal Swab Collection. Sterile cotton swab inserted 1–2 cm into each nostril, rotated for 5–10 sec. Placed in labeled sterile containers immediately..

Scene 17 (4m 57s)

LABORATORY METHODS. 2. Transport & Plating. Swabs processed within 4 hrs. Inoculated onto Mannitol Salt Agar (MSA) — selective for S. aureus. Incubated at 37°C for 18–24 hrs..

Scene 18 (5m 10s)

LABORATORY METHODS. 3. Identification. Gram staining confirms Gram-positive cocci. Catalase & coagulase tests confirm S. aureus. Colonies sub-cultured on Blood Agar..

Scene 19 (5m 22s)

LABORATORY METHODS. 4. MRSA Confirmation. Antibiotic susceptibility tested on Müeller-Hinton Agar with Cefoxitin discs (30 µg). Inhibition zone ≤ 21 mm = MRSA (CLSI criteria)..

Scene 20 (5m 34s)

[image]. CHAPTER 04. RESULTS. Prevalence findings · MRSA proportion · Risk factor associations.

Scene 21 (5m 43s)

KEY FINDINGS. Al-Reyada University Students, Aden, Yemen · n = 150.

Scene 22 (6m 11s)

RISK FACTOR ANALYSIS. MRSA Rate By Age 21-18 25-21 30-25 8.5 3.2 0.

Scene 23 (6m 26s)

RISK FACTOR ANALYSIS. 10 7 Isolates MRSA (58.8%) MSSA (41.2%).

Scene 24 (6m 55s)

[image]. CHAPTER 05. DISCUSSION. Contextualizing our findings against regional & global literature.

Scene 25 (7m 4s)

DISCUSSING OUR RESULTS. S. aureus Carriage (11.3%).

Scene 26 (7m 46s)

DISCUSSING OUR RESULTS. Smoking:. Our Study. Smokers: 18.8% vs Non-smokers: 5.2% (p=0.040).

Scene 27 (8m 14s)

DISCUSSING OUR RESULTS. Microbiological Culture Results and Distribution of Bacterial Isolates.

Scene 28 (8m 28s)

[image]. CHAPTER 06. CONCLUSIONS and RECOMMENDATIONS.

Scene 29 (8m 38s)

CONCLUSIONS. 1. S. aureus nasal carriage prevalence was 11.3% (17/150) — a moderate colonization rate among university students in Aden..

Scene 30 (9m 16s)

RECOMMENDATIONS. University Administration. › Implement regular MRSA screening for students in dormitories & shared housing.

Scene 31 (9m 53s)

logo. last. Thank You. For Your Attention. This study serves as a reminder that effective prevention begins long before infection occurs. Every informed action taken today contributes to a safer healthcare environment tomorrow….

Scene 32 (10m 14s)

last. ﴿ ٱلْحَمْدُ لِلَّهِ الَّذِي بِنِعْمَتِهِ تَتِمُّ الصَّالِحَاتُ، وَبِفَضْلِهِ تُبْلَغُ الْغَايَاتُ. ﴾ اللَّهُمَّ اجْعَلْ هَذَا الْعَمَلَ خَالِصًا لِوَجْهِكَ الْكَرِيمِ، نَافِعًا لِلْعِلْمِ وَالْوَطَنِ، وَبَارِكْ فِيهِ وَتَقَبَّلْهُ مِنَّا بِقَبُولٍ حَسَنٍ. ﴿ وَآخِرُ دَعْوَاهُمْ أَنِ ٱلْحَمْدُ لِلَّهِ رَبِّ ٱلْعَالَمِينَ. ﴾.